Amicus Therapeutics, Inc.

NasdaqGM:FOLD Stok Raporu

Piyasa değeri: US$3.2b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Amicus Therapeutics Yönetim

Yönetim kriter kontrolleri 4/4

Amicus Therapeutics' CEO'su Brad Campbell, Jan2015 tarihinde atandı, in görev süresi 9.75 yıldır. in toplam yıllık tazminatı $ 8.20M olup, şirket hissesi ve opsiyonları dahil olmak üzere 8.5% maaş ve 91.5% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.3% ine doğrudan sahiptir ve bu hisseler $ 9.47M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 7.6 yıl ve 6.2 yıldır.

Anahtar bilgiler

Brad Campbell

İcra Kurulu Başkanı

US$8.2m

Toplam tazminat

CEO maaş yüzdesi8.5%
CEO görev süresi9.8yrs
CEO sahipliği0.3%
Yönetim ortalama görev süresi7.6yrs
Yönetim Kurulu ortalama görev süresi6.2yrs

Son yönetim güncellemeleri

Recent updates

'Boring' Amicus Therapeutics Is Making Progress

Sep 29

Amicus Therapeutics: A Compelling Investment In The Rare Disease Biotech Sector

Aug 16

Little Excitement Around Amicus Therapeutics, Inc.'s (NASDAQ:FOLD) Revenues

Jul 02
Little Excitement Around Amicus Therapeutics, Inc.'s (NASDAQ:FOLD) Revenues

Here's Why Amicus Therapeutics (NASDAQ:FOLD) Can Afford Some Debt

Jun 06
Here's Why Amicus Therapeutics (NASDAQ:FOLD) Can Afford Some Debt

Amicus Therapeutics: Too Cheap At Under $10 A Share

May 20

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Looks Inexpensive But Perhaps Not Attractive Enough

Mar 27
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Looks Inexpensive But Perhaps Not Attractive Enough

Amicus Therapeutics: Expect Improved Commercial Momentum In 2024

Feb 29

Amicus Therapeutics, Inc.'s (NASDAQ:FOLD) Share Price Could Signal Some Risk

Dec 19
Amicus Therapeutics, Inc.'s (NASDAQ:FOLD) Share Price Could Signal Some Risk

Amicus Therapeutics (NASDAQ:FOLD) Is Carrying A Fair Bit Of Debt

Jul 06
Amicus Therapeutics (NASDAQ:FOLD) Is Carrying A Fair Bit Of Debt

Amicus Therapeutics, Inc.'s (NASDAQ:FOLD) Revenues Are Not Doing Enough For Some Investors

May 14
Amicus Therapeutics, Inc.'s (NASDAQ:FOLD) Revenues Are Not Doing Enough For Some Investors

Does Amicus Therapeutics (NASDAQ:FOLD) Have A Healthy Balance Sheet?

Mar 23
Does Amicus Therapeutics (NASDAQ:FOLD) Have A Healthy Balance Sheet?

We Think Amicus Therapeutics (NASDAQ:FOLD) Has A Fair Chunk Of Debt

Dec 06
We Think Amicus Therapeutics (NASDAQ:FOLD) Has A Fair Chunk Of Debt

Amicus Therapeutics (NASDAQ:FOLD) Is Carrying A Fair Bit Of Debt

Aug 25
Amicus Therapeutics (NASDAQ:FOLD) Is Carrying A Fair Bit Of Debt

Amicus Therapeutics: AT-GAA Approval Delayed, I Will Continue Holding

Aug 10

Amicus Therapeutics Q2 2022 Earnings Preview

Aug 03

Is Amicus Therapeutics (NASDAQ:FOLD) Weighed On By Its Debt Load?

May 06
Is Amicus Therapeutics (NASDAQ:FOLD) Weighed On By Its Debt Load?

Amicus Therapeutics: An Inflection Point In Growth

Apr 27

CEO Tazminat Analizi

Brad Campbell'un ücretlendirmesi Amicus Therapeutics'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$120m

Mar 31 2024n/an/a

-US$147m

Dec 31 2023US$8mUS$699k

-US$152m

Sep 30 2023n/an/a

-US$174m

Jun 30 2023n/an/a

-US$185m

Mar 31 2023n/an/a

-US$204m

Dec 31 2022US$9mUS$591k

-US$237m

Sep 30 2022n/an/a

-US$264m

Jun 30 2022n/an/a

-US$281m

Mar 31 2022n/an/a

-US$270m

Dec 31 2021US$5mUS$551k

-US$250m

Sep 30 2021n/an/a

-US$239m

Jun 30 2021n/an/a

-US$252m

Mar 31 2021n/an/a

-US$254m

Dec 31 2020US$5mUS$516k

-US$277m

Sep 30 2020n/an/a

-US$295m

Jun 30 2020n/an/a

-US$293m

Mar 31 2020n/an/a

-US$325m

Dec 31 2019US$4mUS$501k

-US$356m

Sep 30 2019n/an/a

-US$345m

Jun 30 2019n/an/a

-US$442m

Mar 31 2019n/an/a

-US$419m

Dec 31 2018US$3mUS$468k

-US$349m

Sep 30 2018n/an/a

-US$340m

Jun 30 2018n/an/a

-US$293m

Mar 31 2018n/an/a

-US$279m

Dec 31 2017US$2mUS$450k

-US$284m

Tazminat ve Piyasa: Brad 'ın toplam tazminatı ($USD 8.20M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 6.79M ).

Tazminat ve Kazançlar: Brad 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Brad Campbell (48 yo)

9.8yrs

Görev süresi

US$8,202,366

Tazminat

Mr. Bradley L. Campbell, also known as Brad, MBA, serves as Director of Gennao Bio, Inc. since March 2022. He serves as Director of Alliance for Regenerative Medicine. He served as Chief Operating Officer...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Bradley Campbell
CEO, President & Director9.8yrsUS$8.20m0.30%
$ 9.5m
Simon Nicolas Harford
Chief Financial Officer1.2yrsUS$3.27m0.0048%
$ 151.4k
Ellen Rosenberg
Chief Legal Officer & Corporate Secretary8.7yrsUS$4.08m0.064%
$ 2.0m
David Clark
Chief People Officer6yrsUS$3.21m0.047%
$ 1.5m
Jeffrey Castelli
Chief Development Officerno dataUS$3.67m0.081%
$ 2.6m
Samantha Prout
Chief Accounting Officer & Controller6.6yrsVeri yok0.025%
$ 788.2k
Jill Weimer
Chief Science Officerno dataVeri yokVeri yok
Andrew Faughnan
Senior Director of Investor Relationsno dataVeri yokVeri yok
Patrik Florencio
Global Chief Compliance & Risk Officer9.2yrsVeri yokVeri yok
Diana Moore
Head of Global Corporate Communicationsno dataVeri yokVeri yok
Jayne Gershkowitz
Chief Patient Advocate9.1yrsVeri yokVeri yok
Julie Yu
Chief Program Officer4.4yrsVeri yokVeri yok

7.6yrs

Ortalama Görev Süresi

54.5yo

Ortalama Yaş

Deneyimli Yönetim: FOLD 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.6 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Bradley Campbell
CEO, President & Director6.3yrsUS$8.20m0.30%
$ 9.5m
Burke Whitman
Independent Director5.3yrsUS$391.25k0.026%
$ 829.0k
Michael Kelly
Independent Director3.8yrsUS$391.25k0.0099%
$ 313.6k
Glenn Sblendorio
Independent Director18.3yrsUS$407.07k0.025%
$ 799.6k
Margaret McGlynn
Independent Director15yrsUS$401.25k0.017%
$ 540.6k
Michael Raab
Chairman & Lead Independent Director20.8yrsUS$426.25k0.025%
$ 799.6k
Eiry Roberts
Independent Director3.3yrsUS$390.00k0.0081%
$ 256.4k
Lynn Bleil
Independent Director6.1yrsUS$397.50k0.025%
$ 779.3k

6.2yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: FOLD 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.2 yıldır).